カモスタット

Camostat

HCID 2536CAS 59721-28-7

基本情報

標準SMILES
CN(C)C(=O)COC(=O)Cc1ccc(OC(=O)c2ccc(N=C(N)N)cc2)cc1
InChIKey
XASIMHXSUQUHLV-UHFFFAOYSA-N
分子式
C20H22N4O5
平均分子量
398.4 g/mol
単同位体質量
398.1590198

概要

Camostat is a benzoate ester resulting from the formal condensation of the carboxy group of 4-guanidinobenzoic acid with the hydroxy group of 2-(dimethylamino)-2-oxoethyl (4-hydroxyphenyl)acetate. It is a potent inhibitor of the human transmembrane protease serine 2 (TMPRSS2) and its mesylate salt is currently under investigation for its effectiveness in COVID-19 patients. It has a role as an anticoronaviral agent, an antiviral agent, an antineoplastic agent, an antihypertensive agent, an antifibrinolytic drug, a serine protease inhibitor and an anti-inflammatory agent. It is a tertiary carboxamide, a member of guanidines, a carboxylic ester, a benzoate ester and a diester. It is functionally related to a 4-guanidinobenzoic acid. It is a conjugate base of a camostat(1+).

名称と識別子

優先名称
Camostat
IUPAC
[4-[2-[2-(dimethylamino)-2-oxoethoxy]-2-oxoethyl]phenyl] 4-(diaminomethylideneamino)benzoate
現地名
カモスタット
英語名
Camostat
分子式
C20H22N4O5
分子量
398.41

名称と別名

Camostat59721-28-7camostateCamostatum0FD207WKDUDTXSID6044010CHEBI:135632p-Guanidinobenzoic acid, ester with (p-hydroxyphenyl)acetic acid, ester with N,N-dimethylglycolamide4-{2-[(dimethylcarbamoyl)methoxy]-2-oxoethyl}phenyl 4-carbamimidamidobenzoate(4-(2-(2-dimethylamino-2-oxoethoxy)-2-oxoethyl)phenyl) 4-(diaminomethylideneamino)benzoate[4-[2-(2-dimethylamino-2-oxoethoxy)-2-oxoethyl]phenyl] 4-(diaminomethylideneamino)benzoate4-(2-((dimethylcarbamoyl)methoxy)-2-oxoethyl)phenyl 4-carbamimidamidobenzoate
名称をさらに表示
4-[[4-[(アミノイミノメチル)アミノ]ベンゾイル]オキシ]ベンゼン酢酸2-(ジメチルアミノ)-2-オキソエチル4-グアニジノ安息香酸4-[[[(ジメチルカルバモイル)メトキシ]カルボニル]メチル]フェニル4-グアニジノ安息香酸-4-(ジメチルカルバモイルメトキシカルボニルメチル)フェニル4-[(4-グアニジノベンゾイル)オキシ]ベンゼン酢酸2-(ジメチルアミノ)-2-オキソエチルカモスタットp-(p-グアニジノベンゾイルオキシ)フェニル酢酸=ジメチルカルバモイルメチル[4-[4-(グアニジノ)ベンゾイルオキシ]フェニル]酢酸(ジメチルアミノカルボニルメチル)4-{2-[(ジメチルカルバモイル)メトキシ]-2-オキソエチル}フェニル 4-カルバムイミドアミドベンゾアートCanostatFOY 305Ccris 7219FOY-305:FoipanUnii-0fd207wkduCamostat free baseCamostat formate saltCamostatum [inn-latin]
RefChem:573682DTXCID4024010Camostat [INN]camostat-mesilate[4-[2-[2-(dimethylamino)-2-oxoethoxy]-2-oxoethyl]phenyl] 4-(diaminomethylideneamino)benzoateUS9199927, camostat4-(2-(2-(Dimethylamino)-2-oxoethoxy)-2-oxoethyl)phenyl 4-guanidinobenzoateDimethylcarbamoylmethyl 4-(4-guqnidinobenzoyloxy)phenylacetat

データベース識別子

CAS
59721-28-7
PubChem CID
2536
DTXSID
DTXSID6044010
ChEMBL
CHEMBL590799
ChEBI
CHEBI:135632
UNII
0FD207WKDU
Nikkaji
J23.287D

物性

構造計算による物性

XLogP
1.1
極性表面積
137 Ų
水素結合供与体数
2
水素結合受容体数
6
回転可能結合数
9
重原子数
29

実験および物理化学的性質

Melting Point194-198

物理化学的性質

沸点
590.5 · 590.5±60.0 °C(Predicted)
比重(密度)
1.28 · 1.28±0.1 g/cm3(Predicted)
酸解離定数(Pka)
10.17 · 10.17±0.10(Predicted)

化学と産業

薬理情報

ATC Code · 2 件

B - Blood and blood forming organs

QB - Blood and blood forming organs

Protein BindingCamostat mesylate is 25.8-28.2% protein bound to human serum proteins _in vitro_.
Pharmacodynamics · 1 件

Camostat mesylate is a protease inhibitor used to treat chronic pancreatitis. The duration of action is not long, as it is typically given in 3 divided doses daily. Patients should be counselled regarding the risk of anaphylaxis, thrombocytopenia, hepatic dysfunction, and hyperkalemia.

Mechanism of Action · 1 件

In rats, oral camostat mesylate may increase pancreatic secretions and hypertrophy by increasing cholecystokinin release. Administration in rats has also lead to lower levels of IL-1beta, IL-6, TNF-alpha, TGF-beta, and PSC. Similar activity is seem after administration in humans, leading to reduced pain and inflammation as well as improve the function of the pancrease in chronic pancreatitis. In the case of SARS-CoV-2, camostat mesylate inhibits the action of the serine protease TMPRSS2, preventing the priming of the viral spike protein for attachment to ACE2, and entry into the cell.

Biological Half-LifeThe half life of camostat mesylate is 3.8-4.7h.
Metabolism/MetabolitesCamostat mesylate is hydrolyzed by carboxyesterate to the active 4-(4-guanidinobenzoyloxy) phenylacetate. The active metabolite is further hydrolyzed by arylesterase to 4-guanidinobenzoic acid.

サプライヤー34 社

湖北万得化工有限公司15377098680 15377098680 · [email protected]
普善实业(陕西)有限公司029-81310890 18165209495 · [email protected]
Suzhou ARTK Medchem Co., Ltd.+86-18168183658 · [email protected]
LGM Pharma1-(800)-881-8210 · [email protected]
武汉丰泰威远科技有限公司+86-27-8746-5837 +86-18627785180 · [email protected]

関連反応

0 件

現在のフィルター条件では反応記録がありません。

関連ノート

読み込み中…